Mencarelli, Lucia
Torso, Mario
Borghi, Ilaria
Assogna, Martina
Pezzopane, Valentina
Bonnì, Sonia
Di Lorenzo, Francesco
Santarnecchi, Emiliano
Giove, Federico
Martorana, Alessandro
Bozzali, Marco
Ridgway, Gerard R.
Chance, Steven A.
Koch, Giacomo
Funding for this research was provided by:
BrightFocus Foundation (A2019523S)
Ministero della Salute (Ricerca corrente 2018)
Article History
Received: 18 January 2024
Accepted: 12 June 2024
First Online: 5 July 2024
Declarations
:
: The study was approved by the review board and ethics committee of the Santa Lucia Foundation. All patients or their relatives or legal representatives provided written informed consent.
: Not applicable.
: SAC is a co-founder of a company, Oxford Brain Diagnostics Ltd, from which he has received funding for the research and preparation of this manuscript. MT and GRR are currently employed at a company, Oxford Brain Diagnostics Ltd. SAC has a patent (WO2016162682A1) related to the diffusion MRI analysis used in the present study. G.K. and ES have a patent on precision neuromodulation in patients with Alzheimer’s disease partially including the methodology described in this report (11998740). The remaining authors have no conflicts of interest to declare.